Skip to main content

Advertisement

SpringerLink
Log in

Depressive Symptoms and C-Reactive Protein Are Not Associated in a Population-Based Sample of Adolescents

  • Published:
International Journal of Behavioral Medicine Aims and scope Submit manuscript

Abstract

Background

One potential mechanism to explain the association of depression and cardiovascular mortality is through increased inflammation. Adolescents typically have high levels of depressive symptoms, but the association of depression and levels of inflammation has not been examined within this age group.

Purpose

The objective was to study the association between high-sensitivity C-reactive protein (hs-CRP) concentrations and depressive symptoms in youth.

Method

Data were available for 1,535 adolescents aged 13 and 16 years obtained in a province-wide survey of a representative sample of youth in Quebec, Canada in 1999. Data on depressive symptoms were collected in self-report questionnaires. Participants provided a fasting blood sample, and anthropometric measures were undertaken by trained technicians.

Results

For each unit increase in the depression score, the odds ratio for elevated hs-CRP (i.e., ≥90th percentile value of the age- and sex-specific CRP distribution) was 1.06 (95% confidence interval 0.79, 1.42) after adjustment for age, sex, ever smoked, language, body mass index, physical inactivity, use of medication, total cholesterol concentration, triglycerides concentration, and systolic blood pressure.

Conclusion

These data do not support an association between depressive symptoms and elevated CRP in adolescents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8–19.

    CAS  PubMed  Google Scholar 

  2. Cassano P, Fava M. Depression and public health: an overview. J Psychosom Res. 2002;53(4):849–57.

    Article  PubMed  Google Scholar 

  3. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol. 2005;4(6):371–80.

    Article  CAS  PubMed  Google Scholar 

  4. Tiemeier H, van Dijck W, Hofman A, Witteman JC, Stijnen T, Breteler MM. Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatry. 2004;61(4):369–76.

    Article  PubMed  Google Scholar 

  5. Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry. 1999;4(4):317–27.

    Article  CAS  PubMed  Google Scholar 

  6. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–41.

    Article  CAS  PubMed  Google Scholar 

  7. Cavanagh J, Mathias C. Inflammation and its relevance to psychiatry. Adv Psychiatr Treat. 2008;14:248–55.

    Article  Google Scholar 

  8. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol. 2002;90(12):1279–83.

    Article  PubMed  Google Scholar 

  9. Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev. 1998;105(1):83–107.

    Article  CAS  PubMed  Google Scholar 

  10. Francus T, Romano PM, Manzo G, Fonacier L, Arango N, Szabo P. IL-1, IL-6, and PDGF mRNA expression in alveolar cells following stimulation with a tobacco-derived antigen. Cell Immunol. 1992;145(1):156–74.

    Article  CAS  PubMed  Google Scholar 

  11. Almeida OP, Norman P, Hankey GJ, Jamrozik K, Flicker L. The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the Health in Men Study (HIMS). Psychol Med. 2007;17:1–12.

    Google Scholar 

  12. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon 3rd RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511.

    Article  PubMed  Google Scholar 

  13. Wilson AM, Ryan MC, Boyle AJ. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol. 2006;106(3):291–7.

    Article  PubMed  Google Scholar 

  14. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004;164(9):1010–4.

    Article  PubMed  Google Scholar 

  15. Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med. 2003;65(3):347–56.

    Article  CAS  PubMed  Google Scholar 

  16. Tiemeier H, Hofman A, van Tuijl HR, Kiliaan AJ, Meijer J, Breteler MM. Inflammatory proteins and depression in the elderly. Epidemiology. 2003;14(1):103–7.

    Article  PubMed  Google Scholar 

  17. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, et al. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry. 2003;54(5):566–72.

    Article  CAS  PubMed  Google Scholar 

  18. Suarez EC. C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med. 2004;66(5):684–91.

    Article  CAS  PubMed  Google Scholar 

  19. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14):1387–97.

    Article  CAS  PubMed  Google Scholar 

  20. Elovainio M, Keltikangas-Jarvinen L, Pulkki-Raback L, Kivimaki M, Puttonen S, Viikari L, et al. Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study. Psychol Med. 2006;36(6):797–805.

    Article  PubMed  Google Scholar 

  21. Paradis G, Lambert M, O'Loughlin J, Lavallee C, Aubin J, Berthiaume P, et al. The Quebec Child and Adolescent Health Survey: design and methods of a cardiovascular risk factor survey for youth. Can J Cardiol. 2003;19:523–31.

    PubMed  Google Scholar 

  22. Preville M, Potvin L, Boyer R. The structure of psychological distress. Psychol Rep. 1995;77(1):275–93.

    CAS  PubMed  Google Scholar 

  23. Miller AC, Gordon RM, Daniele RJ, Diller L. Stress, appraisal, and coping in mothers of disabled and nondisabled children. J Pediatr Psychol. 1992;17(5):587–605.

    Article  CAS  PubMed  Google Scholar 

  24. Riddle AS, Blais MR, Hess U. A multi-group investigation of the CES-D's measurement structure across adolescents, young adults and middle-aged adults. Montreal: Centre Interuniversitaire de Recherche en Analyse des Organisations; 2002. Report no.: 2002s-36.

  25. Preville M, Cote G, Boyer R, Hebert R. Detection of depression and anxiety disorders by home care nurses. Aging Ment Health. 2004;8(5):400–9.

    Article  CAS  PubMed  Google Scholar 

  26. Escobedo LG, Reddy M, Giovino GA. The relationship between depressive symptoms and cigarette smoking in US adolescents. Addiction. 1998;93(3):433–40.

    Article  CAS  PubMed  Google Scholar 

  27. Statistics Canada. Canadian Community Health Survey. 2001.

  28. Services USDoHaH. Physical activity and health: a report of the surgeon general. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion 1996.

  29. Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem. 2004;50:1762–8.

    Article  CAS  PubMed  Google Scholar 

  30. O'Loughlin J, Lambert M, Karp I, McGrath J, Gray-Donald K, Barnett T, et al. Association between cigarette smoking and C-reactive protein in a representative, population-based sample of adolescents. Nicotine Tob Res. 2008;10(3):525–32.

    Article  PubMed  Google Scholar 

  31. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Rasanen P, Leinonen M, Meyer-Rochow VB, et al. The association between C-reactive protein levels and depression: results from the Northern Finland 1966 Birth Cohort Study. Biol Psychiatry. 2006;60(8):825–30.

    Article  CAS  PubMed  Google Scholar 

  32. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J, et al. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 2002;89(4):419–24.

    Article  CAS  PubMed  Google Scholar 

  33. Douglas KM, Taylor AJ, O'Malley PG. Relationship between depression and C-reactive protein in a screening population. Psychosom Med. 2004;66(5):679–83.

    Article  CAS  PubMed  Google Scholar 

  34. Almeida OP, Norman PE, Allcock R, van Bockxmeer F, Hankey GJ, Jamrozik K, et al. Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int J Epidemiol. 2009;38(4):1049–59.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Public Health Sciences, University of Toronto, T509 33 Russell St., Toronto, ON, Canada, M5S 2S1

    Michael Chaiton

  2. Department of Social and Preventive Medicine, University of Montreal, Montréal, QC, Canada

    Jennifer O’Loughlin & Igor Karp

  3. Centre de Recherche du CHUM, Montréal, QC, Canada

    Jennifer O’Loughlin & Igor Karp

  4. Institut National de Santé Publique du Québec, Montréal, QC, Canada

    Jennifer O’Loughlin

  5. Department of Pediatrics, CHU Sainte-Justine and University of Montreal, Montréal, QC, Canada

    Marie Lambert

Authors
  1. Michael Chaiton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer O’Loughlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Igor Karp
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marie Lambert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Chaiton.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaiton, M., O’Loughlin, J., Karp, I. et al. Depressive Symptoms and C-Reactive Protein Are Not Associated in a Population-Based Sample of Adolescents. Int.J. Behav. Med. 17, 216–222 (2010). https://doi.org/10.1007/s12529-010-9078-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12529-010-9078-9

Keywords

Search

Navigation